Komori
Nichiban (4218) · PolicyAdvancedLatest Changes in Directors and Officers (2026-07-31): "Other"

Governance through the Board of Directors, Board of Corporate Auditors and Executive Officer System

First written in FY2016. 5 of 11 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-07-31.

11entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q3 – FY2019AdvancedFY2021 – FY20222016: 320162017: 220172018: 020182019: 120192020: 120202021: 120212022: 120222023: 020232024: 020242025: 020252026: 22026
Same theme, other companies

17 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 101 companies compared. The sentences above are computed from all 101.
Full recordFilings, disclosures and news, newest first
  1. FY2022AdvancedAnnual report

    「As of the filing date, the Company's Board of Directors comprises 8 members, including 4 outside directors, and the Company has introduced an executive officer system for the conduct of business operations.」

    The Company has maintained an 8-member Board of Directors, while increasing the number of outside directors from 3 to 4. The Nomination and Compensation Committee is operated with a majority of independent outside directors.
  2. FY2021AdvancedAnnual report

    「To strengthen the fairness, transparency, and objectivity of procedures concerning the nomination and compensation of directors from the following fiscal year and enhance corporate governance, we established a Nomination and Compensation Committee as an advisory body to the Board of Directors.」

    A Nomination and Compensation Committee, with independent outside directors comprising a majority, was established for nomination and compensation procedures from the following fiscal year.
  3. FY2020Change to an 8-member Board of DirectorsAnnual report

    「As of the filing date, the Company's Board of Directors comprised 8 members, including 3 outside directors, and the Company had adopted an executive officer system for business execution.」

    The Board of Directors changed from the previously reported 9 members to 8, with 3 outside directors. The operating structure of holding the Management Strategy Committee twice a month and the Management Execution Committee once a month continues.
  4. FY2019AdvancedAnnual report

    「As of the filing date, the Company's Board of Directors comprised 9 members, including 3 outside directors, and the Company had adopted an executive officer system for business execution.」

    The Board of Directors maintained a 9-member structure, while the number of outside directors increased from 2 to 3. The oversight structure, including 2 outside Audit & Supervisory Board members, is also described.
  5. FY2017AdvancedAnnual report

    「As of the filing date, the Company's Board of Directors comprised 9 members, including 2 outside directors, and the Company had adopted an executive officer system for business execution. In addition, the Company held a Management Strategy Committee meeting twice a month, chaired by the Company's representative director, and a Management Execution Committee meeting once a month attended by all executive officers.」

    The Board of Directors comprises 9 members, with governance operations including the Management Strategy Committee held twice a month and the Management Execution Committee held once a month.
  6. FY2017-Q3AdvancedAnnual report

    「December 2016 Appointed as an outside Audit & Supervisory Board member of the Company (incumbent)」

    Sato Akihiro (佐藤彰紘) was appointed as an outside Audit & Supervisory Board member effective 27 December 2016, resulting in a specific change in the Audit & Supervisory Board structure.
  7. FY2017-Q2RestatedAnnual report

    「Against this economic backdrop, as the first year of Stage 3, the final three-year plan under the Group's medium- to long-term management plan NB100, the Group worked on executing a business growth strategy through customer-focused proactive expansion initiatives and the creation of new value; establishing an optimal group-wide production system aimed at consolidated sales of ¥50 billion; developing globally competitive human resources and improving quality across the Group to establish corporate quality; and strengthening corporate governance.」

    Strengthening corporate governance continues to be one of the key initiatives of Stage 3.
  8. FY2017-Q1RestatedAnnual report

    「Strengthening Corporate Governance」

    Strengthening corporate governance remains one of the key initiatives of Stage 3.
  9. FY2016First statedAnnual report

    「As of the filing date, the Company's Board of Directors comprised 8 members, including 2 outside directors, and the Company had adopted an executive officer system for business execution.」

    The Company has adopted a governance structure combining the Board of Directors, outside directors, an executive officer system, the Audit & Supervisory Board, and the Internal Audit Office.
Moved together

"International Expansion of Medical Products in Asia and Europe" moved the same way as this thread, in the same document, in 4 of its 11 moves.

444443★123456
  1. ★This thread
  2. 1International Expansion of Medical Products in Asia and Europe4×
  3. 2Strengthening efforts to raise product brand awareness and promote sales4×
  4. 3Maintaining the Brand and Strengthening the Earnings Structure4×
  5. 4Creation of Major Development Products4×
  6. 5Strengthening Research into Adhesives, Transdermal Absorption and Environmental Technologies4×
  7. 6Cost Reduction, Environmental Initiatives and Crisis Management through Large-Scale Capital Investment3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nichiban's next results are scheduled for 2026-11-12. Read the earnings preview It last moved in the Changes in Directors and Officers of 2026-07-31: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.